Adenoviral vectors for gene therapy

Area of Science:

• Virology
• Gene Therapy
• Immunology

Background:

• Human adenoviruses serotypes 2 (Ad2) and 5 (Ad5) are widely used for gene delivery due to their versatility.
• However, Ad2 and Ad5 vectors have limitations including broad tropism, inefficient infection of certain cell types, and induction of immune responses.

Purpose of the Study:

• To address the limitations of Ad2 and Ad5 adenoviral vectors for gene therapy.
• To explore strategies for improving cell targeting and reducing immunogenicity of adenoviral vectors.

Main Methods:

• Review of existing literature on adenoviral vector technology.
• Analysis of strategies to overcome tropism and immunogenicity issues.

Main Results:

• Ad2 and Ad5 vectors infect cells based on receptor availability, leading to non-specific targeting and inefficient transduction in some target cells.
• In vivo administration of these vectors triggers both innate and adaptive immune responses, limiting their therapeutic application.

Conclusions:

• Overcoming the tropism and immunogenicity limitations of Ad2 and Ad5 vectors is crucial for realizing their full potential in gene therapy.
• Ongoing research aims to develop modified adenoviral vectors with enhanced specificity and reduced immune reactions for improved gene delivery.